Pre-launch — join the EU founding list for first access & launch pricing.

ProloniqEU
Join the list
Pre-launch · EU founding listMade in GermanyHighest quality

Peptides, done properly.

We hold every peptide to pharmaceutical standards, with a signed Certificate of Analysis on every batch. Much of the grey market sells under a “research use only” label, with heavy-metal contamination or no sterility that can cause lasting harm. We open only when EU regulation allows it.

No payment, no commitment · just first access

Preview the Batch Verifier
100%
Per-batch CoAs, planned∗
5 / 5
Mandatory third-party tests, planned∗
2 labs
Flagship dual verification, planned∗
Day one
Founding list gets first access

∗ The quality standard we intend to hold at launch. Nothing is tested or sold yet — these are the targets we will commit to once EU regulation allows us to operate and sell for human use.

Planned quality floor

Five gates.
One release.

Our planned release gate: every batch will have to clear five independent third-party assays at the lab before a single vial may ship. A single fail will block the entire lot. This is the standard we intend to operate, once EU regulation allows it.

Mandatory assays, plannedon every lot, before release.
If one of five failsLot will be destroyed. No re-test, no re-label, no exception.
Planned independent labs∗
JanoshikAnalytical
EurofinsPharma
KromaSilLaboratories
AnrescoLabs
BMS BioDiagnostics

∗ Intended third-party labs, shown to illustrate the testing standard we plan to hold. No partnership is in place yet. We will engage independent labs only once EU regulation allows us to operate and sell for human use.

Trust architecture

One batch. Five tests. One report per lot.

Generic quality claims are not proof. A per-batch certificate of analysis is.

Every lot we release will pass five mandatory third-party tests at an independent lab before it reaches the catalog. The full report will be published on the Batch Verifier, signed and dated by the lab, with the original PDF linked from the originating lab portal.

For flagship peptides (Semaglutide, Retatrutide, BPC-157) a second independent lab will test the same lot. Both reports appear side by side. Any discrepancy is disclosed, not hidden.

No batch goes live without its CoA.
The founding list

First in line, the day the EU opens the door.

No payment, no commitment, just a standing reservation. We’ll keep you posted on the regulatory timeline and reach out the moment we can ship to you.

  1. First access at launch

    Founding-list members get the opening invite before we open to the public. First pick of every first batch.

  2. Launch pricing, locked

    An early-supporter price reserved for the people who backed us before day one. No catch, no pre-payment.

  3. The regulatory inside track

    Plain-language updates on where EU peptide regulation actually stands. No hype, just the timeline as it moves.

Reserve your spot

Be first when it’s legal. Join the list.

Drop your email below. We’ll only ever use it to tell you when the store opens in your country — and you can leave any time.

No payment, no commitment · just first access